Injective weekly report: trades in tight $3.40 to $3.90 range amid bearish momentum

Injective weekly report: trades in tight $3.40 to $3.90 range amid bearish momentum
Injective rises 3.84% this week

Injective (INJ) is currently trading at $3.65, marking a flat week in absolute terms with minimal movement. The asset remains firmly subdued beneath its weekly MA-20 ($4.43), MA-50 ($4.70), and MA-200 ($9.15), underscoring a persistent, long-term bearish trend and sustained selling pressure.

INJ price prediction
24H 6.18%
$5.5
48H 5.79%
$5.48
7D -3.86%
$4.98
1M 39.38%
$7.22
3M 234.56%
$17.33
6M 191.51%
$15.1
12M 163.51%
$13.65
Current price: $ 5.18 -0.06 1.13%
Real-time Data 00:33
Daily range 5.19 Arrow from to Icon 5.25
Weekly range 4.89 Arrow from to Icon 5.84
Loading...

Highlights

  • INJ trades at $3.65, well below MA-20 ($4.43), MA-50 ($4.70), and MA-200 ($9.15), reinforcing a persistent bearish trend.
  • Daily MACD, ADX, and the Awesome Oscillator confirm strong negative momentum, with RSI and CCI near or in oversold territory.
  • Price is expected to remain constrained within $3.40–$3.90 over the next 5 days, with under 20% probability of a bullish reversal above $4.52.

Bearish momentum deepens as weekly indicators breach oversold levels

On the weekly chart, INJ trades well below all major moving averages, with MA-20, MA-50, and MA-200 continuing to act as overhead resistance and highlighting the strength of the prevailing downtrend. Immediate dynamic resistance is set at the Ichimoku Kijun level ($4.52), while no clear weekly support is indicated, suggesting vulnerability to further declines. Weekly momentum indicators remain bearish, with the RSI pressing into oversold territory, and oscillators like the CCI and Awesome Oscillator reinforcing negative sentiment.

Injective asset chart
Injective price dynamics. Source: TradingView.

Subdued sideways range likely as sellers dominate next week

Looking ahead to the coming week, the most probable scenario is that INJ trades sideways above the $3.60 level, within a price corridor of $3.40 to $3.90, reflecting subdued volatility and a lack of bullish momentum. The likelihood of a short-term rebound is low (below 20%), with technicals continuing to favor sellers. A decisive move above $4.52 could open up upside potential, but this outcome appears unlikely based on current signals. In the bearish scenario, a breakdown below $3.57 could precipitate further weakness given the entrenched downtrend.

Jainam Mehta, market strategist, notes that Injective remained firmly under pressure this week, trading well below all major moving averages and facing sustained bearish momentum. He highlights that with no clear news events and oversold technical conditions failing to attract buyers, the path of least resistance continues to favor sellers in the coming week. Mehta sees a neutral-to-defensive setup, with sideways movement between $3.40 and $3.90 likely unless a decisive breakout above $4.52 occurs. "Until bulls reclaim the $4.52 resistance, I expect range-bound action and would avoid aggressive positioning here."

Last time, analysts noted that Injective is trading below its major moving averages, with technical indicators such as RSI, Stochastic RSI, and CCI signaling oversold conditions amid sustained bearish momentum. The asset is expected to consolidate in a sideways to slightly bearish range between support near $3.50 and resistance around $4.15, with low probability of a sustained upside move without a decisive recovery above key resistance levels.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.